Published in Proc Natl Acad Sci U S A on January 22, 2007
Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem (2009) 2.80
Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci U S A (2007) 2.55
Solid-state NMR studies of amyloid fibril structure. Annu Rev Phys Chem (2011) 2.38
Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol (2011) 1.90
Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc Natl Acad Sci U S A (2008) 1.86
Prion diseases and their biochemical mechanisms. Biochemistry (2009) 1.65
The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry (2010) 1.53
Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem (2011) 1.29
Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J Mol Biol (2008) 1.27
Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. J Biol Chem (2009) 1.27
The structural basis of serpin polymerization studied by hydrogen/deuterium exchange and mass spectrometry. J Biol Chem (2008) 1.08
Prion protein misfolding and disease. Curr Opin Struct Biol (2009) 1.06
Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. PLoS One (2010) 1.06
Cofactor molecules induce structural transformation during infectious prion formation. Structure (2013) 1.05
Prions and the potential transmissibility of protein misfolding diseases. Annu Rev Microbiol (2013) 1.04
Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain. J Biol Chem (2008) 1.02
Unique structural characteristics of the rabbit prion protein. J Biol Chem (2010) 1.02
Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversion. PLoS One (2009) 1.01
Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3. J Biol Chem (2010) 1.00
Structural and hydration properties of the partially unfolded states of the prion protein. Biophys J (2007) 0.99
The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel (2009) 0.98
Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity. J Biol Chem (2012) 0.96
Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids. J Biol Chem (2014) 0.94
Crystal structure of a human prion protein fragment reveals a motif for oligomer formation. J Am Chem Soc (2013) 0.94
Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease. Acta Pharmacol Sin (2011) 0.93
Influence of pH on the human prion protein: insights into the early steps of misfolding. Biophys J (2010) 0.93
Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region. J Biol Chem (2013) 0.92
Core sequence of PAPf39 amyloid fibrils and mechanism of pH-dependent fibril formation: the role of monomer conformation. Biochemistry (2012) 0.92
Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils. J Biol Chem (2011) 0.89
Design of an N-methylated peptide inhibitor of alpha-synuclein aggregation guided by solid-state NMR. J Am Chem Soc (2008) 0.89
Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region. Protein Sci (2009) 0.89
Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants. J Biol Chem (2012) 0.89
Comparative analysis of essential collective dynamics and NMR-derived flexibility profiles in evolutionarily diverse prion proteins. Prion (2011) 0.87
Left handed beta helix models for mammalian prion fibrils. Prion (2008) 0.87
Fibril formation of the rabbit/human/bovine prion proteins. Biophys J (2011) 0.87
Structural determinants of phenotypic diversity and replication rate of human prions. PLoS Pathog (2015) 0.86
Hydrogen-exchange mass spectrometry for the study of intrinsic disorder in proteins. Biochim Biophys Acta (2012) 0.86
Probing the conformation of a prion protein fibril with hydrogen exchange. J Biol Chem (2010) 0.85
Determination of amyloid core structure using chemical shifts. Protein Sci (2012) 0.85
PrP assemblies: spotting the responsible regions in prion propagation. Prion (2011) 0.84
A structural overview of the vertebrate prion proteins. Prion (2007) 0.84
Computer simulation study of amyloid fibril formation by palindromic sequences in prion peptides. Proteins (2011) 0.83
Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replication. J Biol Chem (2012) 0.82
Nanomechanical properties of human prion protein amyloid as probed by force spectroscopy. Biophys J (2008) 0.82
Microsecond unfolding kinetics of sheep prion protein reveals an intermediate that correlates with susceptibility to classical scrapie. Biophys J (2011) 0.82
Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation. J Biol Chem (2015) 0.81
How amide hydrogens exchange in native proteins. Proc Natl Acad Sci U S A (2015) 0.81
Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain. Biochemistry (2012) 0.81
Solution structure and dynamics of the I214V mutant of the rabbit prion protein. PLoS One (2010) 0.81
Phosphorylation as a tool to modulate aggregation propensity and to predict fibril architecture. Chembiochem (2011) 0.81
A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers. PLoS Pathog (2015) 0.81
C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42. J Mol Biol (2015) 0.81
Disulfide mapping reveals the domain swapping as the crucial process of the structural conversion of prion protein. Prion (2011) 0.80
Fibrillization of recombinant bovine prion protein (rec-PrP) in vitro. Dokl Biochem Biophys (2008) 0.79
The effect of β2-α2 loop mutation on amyloidogenic properties of the prion protein. FEBS Lett (2013) 0.79
Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection. Biochemistry (2014) 0.79
Conserved amyloid core structure of stop mutants of the human prion protein. Prion (2013) 0.79
Decrypting Prion Protein Conversion into a β-Rich Conformer by Molecular Dynamics. J Chem Theory Comput (2013) 0.78
Helices 2 and 3 are the initiation sites in the PrP(C) → PrP(SC) transition. Biochemistry (2012) 0.78
Elongation of mouse prion protein amyloid-like fibrils: effect of temperature and denaturant concentration. PLoS One (2014) 0.78
Regions which are Responsible for Swapping are also Responsible for Folding and Misfolding. Open Biochem J (2011) 0.78
Progress towards structural understanding of infectious sheep PrP-amyloid. Prion (2014) 0.78
NMR structure and CD titration with metal cations of human prion alpha2-helix-related peptides. Bioinorg Chem Appl (2007) 0.77
Copper-induced structural propensities of the amyloidogenic region of human prion protein. J Biol Inorg Chem (2014) 0.77
Insight into Early-Stage Unfolding of GPI-Anchored Human Prion Protein. Biophys J (2015) 0.76
Highly polar environments catalyze the unfolding of PrP C helix 1. Eur Biophys J (2010) 0.76
Techniques to elucidate the conformation of prions. World J Biol Chem (2015) 0.76
Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion protein. Prep Biochem Biotechnol (2012) 0.76
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases. Acta Neuropathol Commun (2015) 0.76
How do amino acid substitutions affect the amyloidogenic properties and seeding efficiency of prion peptides. Amino Acids (2013) 0.76
Post-translational modifications in PrP expand the conformational diversity of prions in vivo. Sci Rep (2017) 0.76
Structural underpinnings of prion protein conversion. J Biol Chem (2011) 0.75
The intrinsic helical propensities of the helical fragments in prion protein under neutral and low pH conditions: a replica exchange molecular dynamics study. J Mol Model (2013) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Synthetic mammalian prions. Science (2004) 7.35
In vitro generation of infectious scrapie prions. Cell (2005) 6.86
Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci (2001) 6.61
NMR structure of the mouse prion protein domain PrP(121-231). Nature (1996) 6.37
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry (1991) 5.53
The most infectious prion protein particles. Nature (2005) 5.37
Hydrogen exchange mass spectrometry for the analysis of protein dynamics. Mass Spectrom Rev (2005) 5.23
NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A (2000) 4.80
Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A (1997) 4.10
Correlation of structural elements and infectivity of the HET-s prion. Nature (2005) 4.01
Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry (1993) 3.54
Mammalian prion biology: one century of evolving concepts. Cell (2004) 3.46
Emerging principles of conformation-based prion inheritance. Annu Rev Biochem (2004) 3.36
Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol (2002) 2.99
Pathway complexity of prion protein assembly into amyloid. J Biol Chem (2002) 2.96
Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol (2004) 2.92
The state of the prion. Nat Rev Microbiol (2004) 2.60
In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol (2004) 2.59
Hydrogen exchange methods to study protein folding. Methods (2004) 2.47
Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J (2005) 2.42
Prions as protein-based genetic elements. Annu Rev Microbiol (2002) 2.21
From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A (2004) 2.14
Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci U S A (1996) 2.12
Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell (2005) 2.06
Recent atomic models of amyloid fibril structure. Curr Opin Struct Biol (2006) 2.05
Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc Natl Acad Sci U S A (2000) 2.02
Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem (1999) 1.83
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68
Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level. Proc Natl Acad Sci U S A (2005) 1.65
Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease. Protein Sci (2005) 1.62
Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem (2003) 1.61
Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry (2000) 1.52
X-ray diffraction of scrapie prion rods and PrP peptides. J Mol Biol (1995) 1.47
Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. J Biol Chem (2005) 1.44
Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem (2003) 1.38
Probing the instabilities in the dynamics of helical fragments from mouse PrPC. Proc Natl Acad Sci U S A (2004) 1.31
NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proc Natl Acad Sci U S A (2003) 1.22
Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry (2005) 1.21
The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro. Acc Chem Res (2006) 1.13
Transmissible spongiform encephalopathies and prion protein interconversions. Adv Virus Res (2001) 1.11
Hydrogen/deuterium exchange mass spectrometry--a window into amyloid structure. Acc Chem Res (2006) 1.07
Probing the structure of the infectious amyloid form of the prion-forming domain of HET-s using high resolution hydrogen/deuterium exchange monitored by mass spectrometry. J Biol Chem (2005) 0.97
Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem (2010) 2.57
Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci U S A (2007) 2.55
Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol Cell (2004) 2.39
Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell (2005) 2.06
Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol (2011) 1.90
Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem (2010) 1.88
Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc Natl Acad Sci U S A (2008) 1.86
Prion diseases and their biochemical mechanisms. Biochemistry (2009) 1.65
PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem (2010) 1.62
Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy. J Am Chem Soc (2010) 1.55
Hydrogen/deuterium exchange-mass spectrometry: a powerful tool for probing protein structure, dynamics and interactions. Curr Med Chem (2007) 1.47
The effect of disease-associated mutations on the folding pathway of human prion protein. J Biol Chem (2004) 1.34
Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. J Biol Chem (2009) 1.27
Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry (2005) 1.21
Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc Natl Acad Sci U S A (2003) 1.14
Kinetic intermediate in the folding of human prion protein. J Biol Chem (2002) 1.13
The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry. Biochemistry (2006) 1.12
Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy. J Am Chem Soc (2011) 1.10
Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. J Am Chem Soc (2006) 1.09
The structural basis of serpin polymerization studied by hydrogen/deuterium exchange and mass spectrometry. J Biol Chem (2008) 1.08
Solution structural dynamics of HIV-1 reverse transcriptase heterodimer. Biochemistry (2009) 1.08
Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form. J Biol Chem (2002) 1.08
Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). PLoS Pathog (2012) 1.07
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J (2009) 1.07
Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol (2010) 1.06
The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro. FEBS Lett (2009) 1.04
Atypical effect of salts on the thermodynamic stability of human prion protein. J Biol Chem (2003) 1.03
Different properties of the native and reconstituted heterotrimeric G protein transducin. Biochemistry (2008) 1.03
Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain. J Biol Chem (2008) 1.02
Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity. J Biol Chem (2012) 0.96
Complementary structural mass spectrometry techniques reveal local dynamics in functionally important regions of a metastable serpin. Structure (2008) 0.96
Allosteric suppression of HIV-1 reverse transcriptase structural dynamics upon inhibitor binding. Biophys J (2011) 0.94
Cooperative unfolding of a metastable serpin to a molten globule suggests a link between functional and folding energy landscapes. J Mol Biol (2007) 0.94
Crystal structure of a human prion protein fragment reveals a motif for oligomer formation. J Am Chem Soc (2013) 0.94
Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro. J Biol Chem (2006) 0.93
Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J Mol Biol (2002) 0.93
Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region. J Biol Chem (2013) 0.92
Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS One (2009) 0.90
Folding mechanism of the metastable serpin α1-antitrypsin. Proc Natl Acad Sci U S A (2012) 0.90
Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils. J Biol Chem (2011) 0.89
Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle. J Biol Chem (2012) 0.88
Cellular oxidant stress and advanced glycation endproducts of albumin: caveats of the dichlorofluorescein assay. Arch Biochem Biophys (2002) 0.87
Mechanism of stabilization of Bacillus circulans xylanase upon the introduction of disulfide bonds. Biophys Chem (2006) 0.84
Does changing the predicted dynamics of a phospholipase C alter activity and membrane binding? Biophys J (2013) 0.83
Recombinant human prion protein inhibits prion propagation in vitro. Sci Rep (2013) 0.82
Nanomechanical properties of human prion protein amyloid as probed by force spectroscopy. Biophys J (2008) 0.82
Local and global effects of a cavity filling mutation in a metastable serpin. Biochemistry (2009) 0.81
Local conformational flexibility provides a basis for facile polymer formation in human neuroserpin. Biophys J (2011) 0.80
Effects of glycosylation on the stability and flexibility of a metastable protein: the human serpin α(1)-antitrypsin. Int J Mass Spectrom (2011) 0.79
Efavirenz binding site in HIV-1 reverse transcriptase monomers. Biochemistry (2010) 0.79
The effect of β2-α2 loop mutation on amyloidogenic properties of the prion protein. FEBS Lett (2013) 0.79
Early hydrophobic collapse of α₁-antitrypsin facilitates formation of a metastable state: insights from oxidative labeling and mass spectrometry. J Mol Biol (2012) 0.79
Interaction between prion protein and Aβ amyloid fibrils revisited. ACS Chem Neurosci (2014) 0.78
Thermodynamic stabilization of the folded domain of prion protein inhibits prion infection in vivo. Cell Rep (2013) 0.77
Prion strains under the magnifying glass. Nat Struct Mol Biol (2007) 0.77
Probing serpin conformational change using mass spectrometry and related methods. Methods Enzymol (2011) 0.76
A dimer interface mutation in glyceraldehyde 3-phosphate dehydrogenase regulates its binding to AU-rich RNA. J Biol Chem (2015) 0.75
Structural underpinnings of prion protein conversion. J Biol Chem (2011) 0.75
Protein science: discriminating taste of prions. Nature (2007) 0.75